• Recorded Webinar
  • Adiposity Related Diseases
Obesity is a chronic, serious life threatening disease, but treatments exist. Obesity is associated with an increased risk of CVD and CV-associated mortality.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • Adiposity Related Diseases
In June of 2023 the AASLD updated the nomenclature for NAFLD to Metabolic dysfunction-Associated Steatotic Liver Disease(MASLD).
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
  • Pediatrics
Is the intersection of Childhood Obesity and pediatric sleep problems merely confined to a discussion of poor sleep habits leading to weight gain?
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Obesity is one of the leading causes of the development of type 2 diabetes mellitus.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Insulin resistance (IR) is a common biochemical abnormality in patients with excess adiposity, obesity, and its complications.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Obesity is emerging as a serious and complex health condition affecting about 1 billion people in the world.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Sarcopenic obesity presents numerous risks to health and quality of life.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
During this webinar, Dr.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
 Explore the direct and indirect connections between obesity and heart disease, as well as practical strategies for managing heart disease through obesity treatment.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Review some common definitions of metabolic syndrome and its relationship to the underlying driving force behind its development, insulin resistance.
  • 1.00 AMA PRA Category 1 Credit

Pages